Environmental factors, especially microbiota, modify genetic susceptibility to many chronic diseases. The NGRRC provides an essential resource for local, regional, national and international multidisciplinary investigators to explore the hypothess that commensal bacteria strongly influence physiologic processes in normal hosts and pathogenic inflammatory, metabolic and neoplastic responses in genetically susceptible hosts. This unit provides a resource for broadly based NIH-funded investigators to examine physiologic and pathophysiologic differences in germ-free (sterile) vs. gnotobiotic (known life, selectively colonized) vs. specific pathogen-free mice of different genetic backgrounds, to explore the functional alterations of normal vs. dysbiotic bacterial communities in murine models and human diseases, and to define the functional relevance of bacterial genes. The microbiota can be precisely manipulated by colonizing germ-free rodents with single or multiple commensal or pathogenic bacterial, viral or fungal species using isogenic wild type or genetically engineered bacterial strains. In addition, fecal transplants can be performed from murine models or human donors.
Specific aims : 1. Provide germ-free or selectively colonized wild type and mutant mice or their tissues and cells to NIH-funded investigators. 2. Derive additional GF genetically engineered mouse strains for NIH-funded investigators. 3. Support pilot studies for investigators with novel hypotheses to generate preliminary data for NIH grant applications. 4. Train personnel to develop gnotobiotic facilities in other institutions, 5. Develop innovative techniques to improve our gnotobiotic resource. We provide a unique and essential resource for a multidisciplinary group of NIH-funded investigators to study the physiologic and pathophysiologic function of normal and dysbiotic commensal bacteria, with particular emphasis on gene/environmental interactions in genetically altered mice (transgenic, knockout or spontaneously mutated) with altered physiology and disease phenotypes. In the past 4 years of funding, the NGRRC provided 8930 gnotobiotic mice to 73 investigators in 46 institutions. 62 funded and 11 submitted NIH grants (in 6 Institutes) by 52 investigators depend on gnotobiotic mice from the NGRRC.

Public Health Relevance

Altered microbiota composition (dysbiosis) is associated with a number of inflammatory (IBD, NASH, atherosclerosis), metabolic (diabetes, metabolic syndrome), neoplastic (colon cancer) and even behavioral (depression, autism) disorders. However the functional consequences of these compositional changes and the role of individual bacterial species remain unknown. Selective colonization of gnotobiotic mice with native or genetically engineered bacterial species or defined consortia can determine bacterial function, host/microbial and microbial/microbial interactions.

Agency
National Institute of Health (NIH)
Institute
Office of The Director, National Institutes of Health (OD)
Type
Animal (Mammalian and Nonmammalian) Model, and Animal and Biological Material Resource Grants (P40)
Project #
2P40OD010995-11
Application #
8743594
Study Section
Special Emphasis Panel (ZRG1-BBBP-J (45))
Program Officer
Mirochnitchenko, Oleg
Project Start
2003-07-01
Project End
2019-06-30
Budget Start
2014-09-15
Budget End
2015-06-30
Support Year
11
Fiscal Year
2014
Total Cost
$576,182
Indirect Cost
$197,115
Name
University of North Carolina Chapel Hill
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Pushalkar, Smruti; Hundeyin, Mautin; Daley, Donnele et al. (2018) The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression. Cancer Discov 8:403-416
Rogala, Allison R; Schoenborn, Alexi A; Fee, Brian E et al. (2018) Environmental factors regulate Paneth cell phenotype and host susceptibility to intestinal inflammation in Irgm1-deficient mice. Dis Model Mech 11:
Yan, Jing; Takakura, Ayumi; Zandi-Nejad, Kambiz et al. (2018) Mechanisms of gut microbiota-mediated bone remodeling. Gut Microbes 9:84-92
Eaton, Kathryn; Pirani, Ali; Snitkin, Evan S et al. (2018) Replication Study: Intestinal inflammation targets cancer-inducing activity of the microbiota. Elife 7:
Truax, Agnieszka D; Chen, Liang; Tam, Jason W et al. (2018) The Inhibitory Innate Immune Sensor NLRP12 Maintains a Threshold against Obesity by Regulating Gut Microbiota Homeostasis. Cell Host Microbe 24:364-378.e6
Zhang, Cun-Jin; Wang, Chenhui; Jiang, Meiling et al. (2018) Act1 is a negative regulator in T and B cells via direct inhibition of STAT3. Nat Commun 9:2745
Reese, Aspen T; Cho, Eugenia H; Klitzman, Bruce et al. (2018) Antibiotic-induced changes in the microbiota disrupt redox dynamics in the gut. Elife 7:
Iyer, Shankar S; Gensollen, Thomas; Gandhi, Amit et al. (2018) Dietary and Microbial Oxazoles Induce Intestinal Inflammation by Modulating Aryl Hydrocarbon Receptor Responses. Cell 173:1123-1134.e11
Zou, Jun; Chassaing, Benoit; Singh, Vishal et al. (2018) Fiber-Mediated Nourishment of Gut Microbiota Protects against Diet-Induced Obesity by Restoring IL-22-Mediated Colonic Health. Cell Host Microbe 23:41-53.e4
Chang, Yu-Ling; Rossetti, Maura; Vlamakis, Hera et al. (2018) A screen of Crohn's disease-associated microbial metabolites identifies ascorbate as a novel metabolic inhibitor of activated human T cells. Mucosal Immunol :

Showing the most recent 10 out of 89 publications